ArticleBMC gastroenterology2025
Autoimmune gastritis: clinical and histological study in a Peruvian population.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Sex-Related Differences in the Diagnosis and Evolution of Parietal Cell Antibody-Positive Autoimmune Gastritis: A Large Single-Center Retrospective Cohort Study.Diagnostics (Basel, Switzerland) · 2026Article
- Autoimmune gastritis: a comprehensive review of pathophysiology, risk stratification, and management.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The diagnosis of autoimmune gastritis poses significant challenges, particularly in resource-limited settings where access to serological tests is restricted. This study aimed to evaluate the histological, endoscopic, and serological features of patients diagnosed with autoimmune gastritis in our population.
methodsWe retrospectively reviewed cases diagnosed with autoimmune gastritis at two medical centers in Peru. Clinical data, serological and endoscopic reports were collected for each case, and gastric mucosal tissue samples from the antrum and corpus were histologically examined. Immunohistochemistry was also performed to evaluate neuroendocrine hyperplasia.
resultsHistologically, all 44 cases exhibited atrophy in the corpus, with the majority presenting at advanced stages of the disease (84%). However, endoscopic findings did not correlate with histology, as only 59.09% of cases showed corpus atrophy on endoscopy. Immunohistochemical analysis revealed neuroendocrine hyperplasia in all cases (100%). Anti-intrinsic factor antibody was positive in only 25% of cases, whereas 84.1% showed positivity for anti-parietal cell antibodies.
conclusionHistological evaluation of autoimmune gastritis cases demonstrates significant diagnostic potential, offering an effective alternative to costly and less accessible serological tests, particularly in resource-limited settings like ours.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.